Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study.
Miao MiaoYuhui LiBo HuangJiali ChenYuebo JinMiao ShaoXia ZhangXiaolin SunJing HeZhan-Guo LiPublished in: Rheumatology and therapy (2021)
ClinicalTrials.gov identifier, NCT04062019.
Keyphrases